Lixisenatide: GLP-1 (glucagon like peptide) analogue for type 2 diabetes mellitus
Journal Title: JOURNAL OF MEDICAL COLLEGE CHANDIGARH - Year 2017, Vol 7, Issue 1
Abstract
GLP-1 analogues increase insulin sensitivity and decrease hepatic gluconeogenesis, thereby bringing down the blood sugar levels. Lixisenatide is the newest of the GLP-1 analogues to get USFDA approval for its use in the treatment of patients of type 2 diabetes mellitus, along with dietary measures and exercise.
Authors and Affiliations
Sangeeta Bhanwra, Kaza Ahluwalia
Keywords
Related Articles
- EP ID EP320600
- DOI -
- Views 104
- Downloads 0
Striae rubra following topical application of Clobetasol propionate
Topical corticosteroids rarely cause serious side effects if they are used as instructed. The risk of side effects increases with increased drug potency, length and frequency of treatment and surface area exposed. Local...
Balance and functional assessment in ambulatory elderly patients using Timed Get Up and Go test
Introduction: Falls are a foremost cause of injury and activity limitation in older adults. Falls result in significant personal, social and economic burden. The Timed Get Up and Go test is a commonly used screening tool...
The Green House Effects of Anaesthesia
In last few decades, use of inhalational anesthetic gases has increased significantly due to the introduction of newer inhalational agents with inherent benefits and safety. In recent years, there has been an increasing...
Submandibular abscess in a child : Anaesthetic Considerations
Children with neck abscesses may present in an emergency setting thus catching the physician off guard, wherein the management would depend primarily on the anesthesiologist's experience and available resources. We wish...
Research in Pregnancy: Is it ethical or not ?
Human related research is imperative to provide the evidence on which health care can be based. So, categorical exclusion of any particular group from research results in health disparities and should be considered unjus...